Enhancing hepatitis C treatment in the custodial setting: A national roadmap

Medical Journal of Australia

Volumn 200, Issue 1, 2014, Pages 15-16

  Mina, Michael M ^a   Clark, Paul J ^b,c   Beasley, Holly M ^d   Herawati, Lilie ^e   Butler, Tony G ^f   Lloyd, Andrew R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d DEPARTMENT OF HEALTH   (Australia)

^e Medical Department   (Australia)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

ALCOHOL CONSUMPTION; COMMUNITY CARE; CUSTODY; GENOTYPE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH SERVICE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN RIGHTS; INDIGENOUS PEOPLE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MASS SCREENING; NOTE; PATIENT REFERRAL; PRISONER; TELEMEDICINE; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; AUSTRALIA; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; PRISONERS; PRISONS;

EID: 84892767808     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.10654     Document Type: Note

References (13)

1. Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2012. Sydney: University of New South Wales, 2012.
2. Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis C Sub-Committee. Hepatitis C Virus Projections Working Group: estimates and projections of the hepatitis C virus epidemic in Australia 2006. Sydney: National Centre in HIV Epidemiology and Clinical Research, 2006.
3. Department of Health and Ageing. Third national hepatitis C strategy 2010-2013. Canberra: Commonwealth of Australia, 2010.
4. Gidding HF, Topp L, Middleton M, et al. The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006. J Gastroenterol Hepatol 2009; 24: 1648-1654.
5. Freeman AJ, Dore GJ, Law MG, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001; 34: 809-816.
6. Fattovich G. Progression of hepatitis B and C to hepatocellular carcinoma in Western countries. Hepatogastroenterology 1998; 45 Suppl 3: 1206-1213.
7. Sarrazin C, Hézode C, Zeuzem S, Pawlotsky JM. Antiviral strategies in hepatitis C virus infection. J Hepatol 2012; 56 Suppl 1: S88-S100.
8. Butler T, Papanastasiou C. National prison entrants' bloodborne virus and risk behaviour survey report 2004 and 2007. Perth: National Drug Research Institute, 2008.
9. Boonwaat L, Haber PS, Levy MH, Lloyd AR. Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. Med J Aust 2010; 192: 496-500.
10. Bate JP, Colman AJ, Frost PJ, et al. High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C. J Gastroenterol Hepatol 2010; 25: 1276-1280.
11. Batey RG, Jones T, McAllister C. Prisons and HCV: a review and a report on an experience in New South Wales Australia. Int J Prison Health 2008; 4: 156-163.
12. Post JJ, Arain A, Lloyd AR. Enhancing assessment and treatment of hepatitis C in the custodial setting. Clin Infect Dis 2013; 57 Suppl 2: S70-S74.
13. Lloyd AR, Clegg J, Lange J, et al. Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting. Clin Infect Dis 2013; 56: 1078-1084.